C-Rad AB (LTS:0R44) Total Operating Expense: kr260.4 Mil (TTM As of Mar. 2026)


LTS:0R44 C-Rad AB LTS:0R44
83 GF Score
Price kr35.00
GF Value kr33.56
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is C-Rad AB Total Operating Expense?

C-Rad AB LTS:0R44 83 Total Operating Expense is kr260.4 Mil as of Mar. 2026. GuruFocus rates LTS:0R44 with a GF Score™ of 83/100 and a GF Value™ of kr33.56 (Fairly Valued). The stock has 4 warning signs investors should review.

C-Rad AB's Total Operating Expense for the three months ended in Mar. 2026 was kr64.6 Mil. C-Rad AB's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was kr260.4 Mil.

C-Rad AB Total Operating Expense Related Terms

C-Rad AB Total Operating Expense Historical Data

* Premium members only.

The historical data trend for C-Rad AB's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

C-Rad AB Total Operating Expense Chart

C-Rad AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 133.66 183.55 237.41 252.58 255.41

C-Rad AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.90 64.70 61.40 69.70 64.60
LTS:0R44
83GF Score
C-Rad AB LTS:0R44
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

C-Rad AB Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr260.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of kr260.4 Mil mean?
C-Rad AB (LTS:0R44) has a Total Operating Expense of kr260.4 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on C-Rad AB and its competitors.
Is C-Rad AB's Total Operating Expense too high?
C-Rad AB's current Total Operating Expense is kr260.4 Mil. Overall, C-Rad AB has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does C-Rad AB's Total Operating Expense compare to ABT and SYK?
C-Rad AB's Total Operating Expense of kr260.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on C-Rad AB and its competitors. C-Rad AB's current Total Operating Expense is kr260.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is C-Rad AB stock overvalued right now?
Based on GuruFocus' analysis, C-Rad AB (LTS:0R44) is currently considered Fairly Valued. The stock's GF Value™ is kr33.56, compared to a current price of kr35.00 — trading 4.3% above its estimated fair value. The current Total Operating Expense is kr260.4 Mil. C-Rad AB's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For C-Rad AB (LTS:0R44), the current Total Operating Expense is kr260.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is C-Rad AB (LTS:0R44) Overvalued in 2026?

Based on GuruFocus' analysis, C-Rad AB stock appears to be overvalued. The current stock price of kr35.00 is trading 4.3% above its estimated GF Value™ of kr33.56. GuruFocus considers C-Rad AB to be Fairly Valued.

Key valuation signals for LTS:0R44:

  • Total Operating Expense: kr260.4 Mil
  • GF Value™: kr33.56 vs. price of kr35.00 (4.3% above fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the LTS:0R44 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

C-Rad AB Business Description

Other Exchanges CRAD B:Sweden24C:Germany
Address Sjukhusvagen 12K, Uppsala, SWE, 753 09
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Asia Pacific region, and also has its presence in Europe, Middle East and Africa and the rest from Americas.
83GF Score

Get the complete analysis for LTS:0R44

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr35.00
Price
kr33.56
GF Value